{"id":"https://openalex.org/W4392689439","doi":"https://doi.org/10.1158/1541-7786.c.6539863","title":"Data from PI3K and Bcl-2 Inhibition Primes Glioblastoma Cells to Apoptosis through Downregulation of Mcl-1 and Phospho-BAD","display_name":"Data from PI3K and Bcl-2 Inhibition Primes Glioblastoma Cells to Apoptosis through Downregulation of Mcl-1 and Phospho-BAD","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4392689439","doi":"https://doi.org/10.1158/1541-7786.c.6539863"},"language":"en","primary_location":{"id":"doi:10.1158/1541-7786.c.6539863","doi":"https://doi.org/10.1158/1541-7786.c.6539863","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1541-7786.c.6539863","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1541-7786.c.6539863","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003635959","display_name":"Fresia G. Pareja","orcid":"https://orcid.org/0000-0003-3748-8049","observed_orcids":["https://orcid.org/0000-0003-3748-8049"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fresia Pareja","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"David Macleod","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Macleod","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100347287","display_name":"Chang Shu","orcid":"https://orcid.org/0000-0001-9102-0899","observed_orcids":["https://orcid.org/0000-0001-9102-0899"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chang Shu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066548665","display_name":"John F. Crary","orcid":"https://orcid.org/0000-0002-0556-293X","observed_orcids":["https://orcid.org/0000-0002-0556-293X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John F. Crary","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046673359","display_name":"Peter Canoll","orcid":"https://orcid.org/0000-0002-7001-0226","observed_orcids":["https://orcid.org/0000-0002-7001-0226"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter D. Canoll","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090059410","display_name":"Alonzo H. Ross","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alonzo H. Ross","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5019896041","display_name":"Markus David Siegelin","orcid":"https://orcid.org/0000-0001-7113-3634","observed_orcids":["https://orcid.org/0000-0001-7113-3634"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Markus D. Siegelin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.7451000213623047,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.7451000213623047,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.20229999721050262,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.019899999722838402,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.921999990940094},{"id":"https://openalex.org/keywords/pi3k-inhibition","display_name":"PI3K inhibition","score":0.8410000205039978},{"id":"https://openalex.org/keywords/bcl-2-inhibition","display_name":"BCL-2 inhibition","score":0.9660000205039978},{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.7940000295639038},{"id":"https://openalex.org/keywords/bad-phosphorylation","display_name":"Bad phosphorylation","score":0.9789999723434448},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6539999842643738},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7699999809265137},{"id":"https://openalex.org/keywords/navitoclax","display_name":"navitoclax","score":0.8820000290870667},{"id":"https://openalex.org/keywords/gdc-0941","display_name":"GDC-0941","score":0.9950000047683716},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.7549999952316284},{"id":"https://openalex.org/keywords/caspase-activation","display_name":"caspase activation","score":0.746999979019165},{"id":"https://openalex.org/keywords/neurospheres","display_name":"neurospheres","score":0.7979999780654907},{"id":"https://openalex.org/keywords/mitochondrial-membrane-potential","display_name":"mitochondrial membrane potential","score":0.6660000085830688},{"id":"https://openalex.org/keywords/anti-apoptotic-proteins","display_name":"anti-apoptotic proteins","score":0.6710000038146973},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.46399998664855957}],"concepts":[{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.8460542559623718},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6537689566612244},{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.5685152411460876},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5679078102111816},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4596964418888092},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4483741521835327},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2578592300415039},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.12795406579971313},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12455174326896667}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1541-7786.c.6539863","doi":"https://doi.org/10.1158/1541-7786.c.6539863","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1541-7786.c.6539863","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1541-7786.c.6539863","doi":"https://doi.org/10.1158/1541-7786.c.6539863","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1541-7786.c.6539863","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2164180823","https://openalex.org/W2116852577","https://openalex.org/W1543856063","https://openalex.org/W4406054223","https://openalex.org/W1989414412","https://openalex.org/W1967462095","https://openalex.org/W840890","https://openalex.org/W2060105071","https://openalex.org/W4361247189","https://openalex.org/W2122452009"],"abstract_inverted_index":{"Abstract":[0],"Glioblastoma":[1],"multiforme":[2],"(GBM)":[3],"is":[4,54],"a":[5,17,55,69,90,100,124,151,209],"highly":[6],"malignant":[7],"human":[8,223],"brain":[9],"neoplasm":[10],"with":[11,21,97,123,168,251],"limited":[12],"therapeutic":[13,57,257],"options.":[14],"GBMs":[15],"display":[16],"deregulated":[18,264],"apoptotic":[19,109,226],"pathway":[20,47],"high":[22],"levels":[23,190],"of":[24,29,34,44,52,103,108,136,156,163,178,203,217,222,240],"the":[25,35,45,49,134,197,200,215,231,237],"antiapoptotic":[26],"Bcl-2":[27,50,65],"family":[28,51],"proteins":[30,53],"and":[31,48,67,78,106,117,145,153,161,181,191,212,253],"overt":[32],"activity":[33],"phosphatidylinositol":[36],"3-kinase":[37],"(PI3K)":[38],"signaling":[39],"pathway.":[40],"Therefore,":[41],"combined":[42],"interference":[43],"PI3K":[46,70],"reasonable":[56],"strategy.":[58],"ABT-263":[59,98,116,144,252],"(Navitoclax),":[60],"an":[61,120],"orally":[62],"available":[63],"small-molecule":[64],"inhibitor,":[66,71],"GDC-0941,":[68,146],"were":[72],"used":[73],"to":[74,141,175,271],"treat":[75],"established":[76],"glioblastoma":[77,79],"neurosphere":[80],"cells,":[81],"alone":[82,88],"or":[83],"in":[84,127,147,150,208,266],"combination.":[85,233],"Although":[86],"GDC-0941":[87,118,185,205,235,254],"had":[89],"modest":[91],"effect":[92],"on":[93],"cell":[94,104,110,227,246],"viability,":[95],"treatment":[96,132,173],"displayed":[99],"marked":[101],"reduction":[102],"viability":[105],"induction":[107],"death.":[111,247],"Moreover,":[112],"combinatorial":[113],"therapy":[114,250],"using":[115],"showed":[119],"enhanced":[121,176],"effect,":[122],"further":[125,243],"decrease":[126],"cellular":[128],"viability.":[129],"Furthermore,":[130,234],"combination":[131,172],"abrogated":[133],"ability":[135],"stem":[137],"cell\u2013like":[138],"glioma":[139],"cells":[140,160],"form":[142],"neurospheres.":[143],"combination,":[148],"resulted":[149],"consistent":[152],"significant":[154],"increase":[155],"Annexin":[157],"V":[158],"positive":[159],"loss":[162],"mitochondrial":[164],"membrane":[165],"potential":[166,258],"compared":[167],"either":[169],"monotherapy.":[170],"The":[171],"led":[174],"cleavage":[177],"both":[179],"initiator":[180],"effector":[182],"caspases.":[183],"Mechanistically,":[184],"depleted":[186],"pAKT":[187],"(Serine":[188],"473)":[189],"suppressed":[192],"Mcl-1":[193,207,218,224],"protein":[194],"levels,":[195],"lowering":[196],"threshold":[198],"for":[199],"cytotoxic":[201],"actions":[202],"ABT-263.":[204],"decreased":[206,214],"posttranslational":[210],"manner":[211],"significantly":[213],"half-life":[216],"protein.":[219],"Ectopic":[220],"expression":[221],"mitigated":[225],"death":[228],"induced":[229],"by":[230,259],"drug":[232],"modulated":[236],"phosphorylation":[238],"status":[239],"BAD,":[241],"thereby":[242],"enhancing":[244],"ABT-263\u2013mediated":[245],"Implications:":[248],"Combination":[249],"has":[255],"novel":[256],"specifically":[260],"targeting":[261],"aberrantly":[262],"active,":[263],"pathways":[265],"GBM,":[267],"overcoming":[268],"endogenous":[269],"resistance":[270],"apoptosis.":[272],"Mol":[273],"Cancer":[274],"Res;":[275],"12(7);":[276],"987\u20131001.":[277],"\u00a92014":[278],"AACR.":[279]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-03-13T00:00:00"}